- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Arrowhead Research Corporation (NASDAQ: ARWR), announced today that Arthur L. Swift has been
appointed Chief Executive Officer & President of its majority-owned
subsidiary, Unidym, Inc., a leader in the development and manufacture
of carbon nanotubes for applications in the electronics industry.
Unidym, which recently merged with Carbon Nanotechnologies,
Incorporated (CNI), possesses a foundational patent portfolio that
covers nearly every aspect of carbon nanotube manufacturing and
"Art has a track record of success in selling and licensing new
products and technologies to electronics manufacturers," said R.
Bruce Stewart, Arrowhead's CEO & Chairman. "His depth and breadth of
executive, technical, and marketing experience in the industry will
be of enormous benefit to Unidym as it executes its business plans."
"I expect Unidym to transform several potentially high volume
applications within the electronics industry," commented Swift.
"Unidym's technology likely will enable more robust touch screens,
lower cost flat panel displays, more efficient thin-film solar cells,
and may even make flexible electronics truly practical. Plus, the
company's IP portfolio provides licensing opportunities as well as
considerable barriers to any future competition. I'm excited to have
the opportunity to contribute to Unidym's success."
Mr. Swift comes to Unidym from Transmeta Corporation, an innovative
semiconductor company in the Silicon Valley, where he most recently
held the position of President and Chief Executive Officer. Prior to
his promotion to CEO, he was Senior Vice President of Marketing. At
Transmeta, Mr. Swift was instrumental in transforming the company's
strategy from selling semiconductor chips to developing and licensing
intellectual property, a change that nearly doubled Transmeta's
revenue in the first two years after the strategy shift.
Prior to Transmeta, Art held senior leadership roles ranging from
President and Chief Operating Officer at an embedded software
startup, Lynuxworks, to Vice President and General Manager at a
variety of large divisions of the established chip-maker Cirrus
Logic. Art has also held senior marketing and engineering positions
with Summit Microelectronics, Sun Microsystems, Digital Equipment,
and Fairchild Semiconductor.
Mr. Swift earned a B.S. in Electrical Engineering at the Pennsylvania
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) is a
publicly-traded nanotechnology company commercializing new
technologies in the areas of life sciences, electronics, and energy.
Arrowhead is building value for shareholders through the progress of
majority owned subsidiaries founded on nanotechnologies originally
developed at universities. The company works closely with
universities to source early stage deals and to generate rights to
intellectual property covering promising new nanotechnologies.
Currently, Arrowhead has four subsidiaries commercializing nanotech
products and applications, including anti-cancer drugs, RNAi
therapeutics, carbon-based electronics and compound semiconductor
About Unidym, Inc.
Unidym is a leader in the manufacture and application of carbon
nanotubes (CNTs), a novel material with extraordinary electrical,
thermal, and mechanical properties. Unidym provides bulk materials,
CNT-enabled products, and intellectual property to a wide range of
customers and business partners. As a result of its recent merger
with CNI, Unidym possesses a foundational patent portfolio that
covers nearly every aspect of CNT manufacturing and processing as
well as multiple product applications.
Unidym is focused on the electronics industry where its initial
products include transparent electrodes for touch screens, flat panel
displays, solar cells, and solid state lighting; electrodes for fuel
cells; and thin film transistors for printable electronics. Unidym is
also pursuing an aggressive, cross-industry partnership strategy to
capture value from the wide ranging uses of CNTs. Undiym's licensing
program, technical expertise and manufacturing facilities can enable
partners to rapidly develop CNT solutions for their specific
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995
This news release contains forward-looking statements within the
meaning ofthe "safe harbor" provisions of the Private Securities
Litigation Reform Actof 1995. These statements are based upon our
current expectations and speak only as of the date hereof. Our actual
results may differ materially and adversely from those expressed in
any forward-looking statements as a result of various factorsand
uncertainties, including the future success of our scientific
studies, our ability to successfully develop products, rapid
technological change in our markets, changes in demand for our future
products, legislative, regulatory and competitive developments and
general economic conditions. Our Annual Report on Form 10-K and
10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and
10-Q/A, recent Current Reports on Forms 8-K and 8-K/A, our
Registration Statement on Form S-3, and other SEC filingsdiscuss some
of the important risk factors that may affect our business, results
of operations and financial condition. We undertake no obligation to
revise or update publicly any forward-looking statements for any
For more information, please click here
Virginia Dadey; Vice President, Investor Relations
Copyright © Arrowhead Research CorporationIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Chad Mirkin receives nanotechnology prize in Russia October 26th, 2016
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016